165 related articles for article (PubMed ID: 29881509)
1. [Primary hodgkin lymphoma of thyroid: case report].
Hadri H; Fares S; Moutiqui T; Lembarki G; Moussali N; Benna NE; Regragui M; Bennani N; Naoumi S; Karkouri M; Quessar A
Pan Afr Med J; 2017; 28():266. PubMed ID: 29881509
[TBL] [Abstract][Full Text] [Related]
2. Primary gastric Hodgkin's lymphoma: A rare coincidence.
Kilaru S; Panda SS; Das H; Sahoo N; Mohapatra D; Mohapatra SSG; Kolluri S
Cancer Treat Res Commun; 2020; 24():100194. PubMed ID: 32707425
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.
Meyer RM; Gospodarowicz MK; Connors JM; Pearcey RG; Bezjak A; Wells WA; Burns BF; Winter JN; Horning SJ; Dar AR; Djurfeldt MS; Ding K; Shepherd LE; ;
J Clin Oncol; 2005 Jul; 23(21):4634-42. PubMed ID: 15837968
[TBL] [Abstract][Full Text] [Related]
4. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
5. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
[TBL] [Abstract][Full Text] [Related]
6. Endobronchial localization of Hodgkin's disease.
Amro L; Jridi S; Sajiai H; Serhane H; Batahar SA
Pan Afr Med J; 2017; 28():9. PubMed ID: 29138655
[TBL] [Abstract][Full Text] [Related]
7. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
8. Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
Behringer K; Goergen H; Hitz F; Zijlstra JM; Greil R; Markova J; Sasse S; Fuchs M; Topp MS; Soekler M; Mathas S; Meissner J; Wilhelm M; Koch P; Lindemann HW; Schalk E; Semrau R; Kriz J; Vieler T; Bentz M; Lange E; Mahlberg R; Hassler A; Vogelhuber M; Hahn D; Mezger J; Krause SW; Skoetz N; Böll B; von Tresckow B; Diehl V; Hallek M; Borchmann P; Stein H; Eich H; Engert A; ; ;
Lancet; 2015 Apr; 385(9976):1418-27. PubMed ID: 25539730
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of Hodgkin's lymphoma: at times a challenge.
Abbasi NZ; Jalal-ud-Din M; Zahur Z; Khan AA; Sheikh AS; Ali F; Memon KH
J Coll Physicians Surg Pak; 2013 Oct; 23(10):752-3. PubMed ID: 24112267
[TBL] [Abstract][Full Text] [Related]
10. Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.
Engert A; Franklin J; Eich HT; Brillant C; Sehlen S; Cartoni C; Herrmann R; Pfreundschuh M; Sieber M; Tesch H; Franke A; Koch P; de Wit M; Paulus U; Hasenclever D; Loeffler M; Müller RP; Müller-Hermelink HK; Dühmke E; Diehl V
J Clin Oncol; 2007 Aug; 25(23):3495-502. PubMed ID: 17606976
[TBL] [Abstract][Full Text] [Related]
11. Hodgkin's disease of appendix: report of a case.
Umer MA; Date RS; Mellor S; Nair B; Ward JB
Colorectal Dis; 2009 Nov; 11(9):985-7. PubMed ID: 19175635
[TBL] [Abstract][Full Text] [Related]
12. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study.
Agostinelli C; Gallamini A; Stracqualursi L; Agati P; Tripodo C; Fuligni F; Sista MT; Fanti S; Biggi A; Vitolo U; Rigacci L; Merli F; Patti C; Romano A; Levis A; Trentin L; Stelitano C; Borra A; Piccaluga PP; Hamilton-Dutoit S; Kamper P; Zaucha JM; Małkowski B; Kulikowski W; Tajer J; Subocz E; Rybka J; Steidl C; Broccoli A; Argnani L; Gascoyne RD; d'Amore F; Zinzani PL; Pileri SA
Lancet Haematol; 2016 Oct; 3(10):e467-e479. PubMed ID: 27692305
[TBL] [Abstract][Full Text] [Related]
13. ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
Viviani S; Zinzani PL; Rambaldi A; Brusamolino E; Levis A; Bonfante V; Vitolo U; Pulsoni A; Liberati AM; Specchia G; Valagussa P; Rossi A; Zaja F; Pogliani EM; Pregno P; Gotti M; Gallamini A; Rota Scalabrini D; Bonadonna G; Gianni AM; ; ;
N Engl J Med; 2011 Jul; 365(3):203-12. PubMed ID: 21774708
[TBL] [Abstract][Full Text] [Related]
14. Classical Hodgkin's lymphoma: past, present and future perspectives.
Eyre TA; King AJ; Collins GP
Br J Hosp Med (Lond); 2013 Nov; 74(11):612-8. PubMed ID: 24220522
[No Abstract] [Full Text] [Related]
15. A Case of Paraneoplastic Cerebellar Degeneration that Preceded the Diagnosis of Classical Hodgkin's Lymphoma by 16 Months.
Arratibel N; Sobejano E; Moran JC; Diaz LG; Blázquez A; Baile M; Veiga Á; Caballero MD; García-Sanz R
Am J Case Rep; 2020 Jun; 21():e922342. PubMed ID: 32574156
[TBL] [Abstract][Full Text] [Related]
16. Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
Diehl V
J Clin Oncol; 2003 Feb; 21(4):583-5. PubMed ID: 12586791
[No Abstract] [Full Text] [Related]
17. [Particularities of Hodgkin's lymphoma].
Mounier N; Fermé C
Rev Prat; 2010 Jan; 60(1):75-9. PubMed ID: 20222316
[TBL] [Abstract][Full Text] [Related]
18. Treatment of lymphocyte-predominant Hodgkin lymphoma.
Engert A
Ann Oncol; 2008 Jun; 19 Suppl 4():iv45-6. PubMed ID: 18519402
[No Abstract] [Full Text] [Related]
19. [Esophageal localization revealing Hodgkin's disease].
Hauteville D; Abgrall J; Chatelain JD; Verdier M; Jan P; Jaubert D
Ann Med Interne (Paris); 1987; 138(1):38-40. PubMed ID: 2438969
[TBL] [Abstract][Full Text] [Related]
20. ABVD chemotherapy of Hodgkin's disease.
Molnár Z; Schneider T; Várady E; Fleischmann T
Neoplasma; 1997; 44(4):263-5. PubMed ID: 9473781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
